Publications Durham NC | HIV Publications & Articles

A glycosylation benchmark profile for HIV-1 envelope glycoprotein production based on eleven Env trimers.

Go EP, Ding H, Zhang S, Ringe RP, Nicely N, Hua D, Steinbock RT, Golabek M, Alin J, Alam SM, Cupo A, Haynes BF, Kappes JC, Moore JP, Sodroski JG, Desaire H.

The Quest for an Antibody-Based HIV Vaccine.

Haynes BF, Mascola JR.

Potent and broad HIV-neutralizing antibodies in memory B cells and plasma

LaTonya D. Williams, Gilad Ofek, Sebastian Schätzle, Jonathan R. McDaniel, Xiaozhi Lu, Nathan I. Nicely, Liming Wu, Caleb S. Lougheed, Todd Bradley, Mark K. Louder, Krisha McKee, Robert T. Bailer, Sijy O’Dell, Ivelin S. Georgiev, Michael S. Seaman, Robert J. Parks, Dawn J. Marshall, Kara Anasti, Guang Yang, Xiaoyan Nie, Nancy L. Tumba, Kevin Wiehe, Kshitij Wagh, Bette Korber, Thomas B. Kepler, S. Munir Alam, Lynn Morris, Gift Kamanga, Myron S. Cohen, Mattia Bonsignori, Shi-Mao Xia, David C. Montefiori, Garnett Kelsoe, Feng Gao, John R. Mascola, M. Anthony Moody, Kevin O. Saunders, Hua-Xin Liao, Georgia D. Tomaras, George Georgiou and Barton F. Haynes. Science Immunology 27 Jan 2017: Vol. 2, Issue 7, DOI: 10.1126/sciimmunol.aal2200

Influence of the Envelope Gp120 Phe 43 Cavity on HIV-1 Sensitivity to ADCC Responses.

Prévost J, Zoubchenok D, Richard J, Veillette M, Pacheco B, Coutu M, Brassard N, Parsons MS, Ruxrungtham K, Bunupuradah T, Tovanabutra S, Hwang KK, Moody MA, Haynes BF, Bonsignori M, Sodroski J, Kaufmann DE, Shaw GM, Chenine AL, Finzi A.

Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness

Iyer SS, Bibollet-Ruche F, Sherrill-Mix S, Learn GH, Plenderleith L, Smith AG, Barbian HJ, Russell RM, Gondim MV, Bahari CY, Shaw CM, Li Y, Decker T, Haynes BF, Shaw GM, Sharp PM, Borrow P, Hahn BH. Proc Natl Acad Sci U S A. 2017 Jan 9. pii: 201620144. doi: 10.1073/pnas.1620144114. [Epub ahead of print]

Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies

Cheeseman HM, Olejniczak NJ, Rogers PM, Evans AB, King DF, Ziprin P, Liao HX, Haynes BF, Shattock RJ.J Virol. 2016 Dec 16;91(1). pii: e01762-16. Print 2017 Jan 1. PMID: 27795431

Genetic and structural analyses of affinity maturation in the humoral response to HIV-1.

Kepler TB, Wiehe K.

Polyvalent vaccine approaches to combat HIV-1 diversity.

Korber B, Hraber P, Wagh K, Hahn BH.

Host controls of HIV broadly neutralizing antibody development.

Kelsoe G, Haynes BF.

Immunodominance of Antibody Recognition of the HIV Envelope V2 Region in Ig-Humanized Mice

Wiehe K, Nicely NI, Lockwood B, Kuraoka M, Anasti K, Arora S, Bowman CM, Stolarchuk C, Parks R, Lloyd KE, Xia SM, Duffy R, Shen X, Kyratsous CA, Macdonald LE, Murphy AJ, Scearce RM, Moody MA, Alam SM, Verkoczy L, Tomaras GD, Kelsoe G, Haynes BF. J Immunol. 2016 Dec 23. pii: 1601640. doi: 10.4049/jimmunol.1601640. [Epub ahead of print]

Publications